Clinical Trials

The James Cancer Center Columbus, OH

open for enrollment

MEDI4736 & Tremelimumab Alone or in Combo w/ High or Low-Dose Radiation in Met Colorectal & NSCLC

Protocol: OSU-17195

Full Title

A Phase II Study of MEDI4736(durvalumab) and Tremelimumab Alone or in Combination with High or Low-Dose Radiation in Metastatic Colorectal and NSCLC